Kick off the New Year in Hawaii with CISCRP as we show our appreciation for Medical Heroes! Medical Heroes are clinical trial study volunteers, healthcare professionals, researchers, and those on the front lines who are treating and caring for the public.
The 2022 Medical Heroes Appreci-a-thon is a team building and outreach campaign in the style of a virtual activity challenge.
Join racers from around the world to log any physical activity completed throughout the month of January–it doesn’t have to be just running or jogging! Each measurement of activity is converted into miles and will pin-point teams on the virtual course in beautiful Hawaii.
More information is available here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.